Paul-Ehrlich-Institut

Information on the Use of Cookies

In order to operate and optimise our website, we would like to collect and analyse statistical information completely anonymously. Will you accept the temporary use of statistics cookies?

You can revoke your consent at any time in our privacy policy.

OK

Publications

Orru' S, Bierbaum S, Enk A, Hengel H, Hoffelner M, Huzly D, Keller-Stanislawski B, Mahler V, Mockenhaupt M, Oberle D (2023): Skin manifestations after immunisation with an adjuvanted recombinant zoster vaccine, Germany, 2020.
Euro Surveill 28: 2300261.
Text


Kehr S, Berg P, Müller S, Fiedler SA, Meyer B, Ruppert-Seipp G, Witzenhausen C, Wolf ME, Henkes HH, Oberle D, Keller-Stanislawski B, Funk MB (2022): Long-term outcome of patients with vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis.
NPJ Vaccines 7: 76.
Online-Abstract


Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S (2021): Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.
N Engl J Med 384: 2092-2101.
Text


Thiele T, Weisser K, Schönborn L, Funk MB, Weber G, Greinacher A, Keller-Stanislawski K (2022): Laboratory confirmed vaccine-induced immune thrombotic thrombocytopenia: Retrospective analysis of reported cases after vaccination with ChAdOx-1 nCoV-19 in Germany.
Lancet Reg Health Eur 12: 100270.
Online-Abstract

Updated: 18.12.2023